About SK Capital
SK Capital is a private equity firm founded in 2008. It is primarily based in New York City, United States. As of Aug 2026, SK Capital is an active investor with a portfolio of 21 companies, comprising 21 funding rounds and 36 acquisitions. In the last 12 months, it has participated in 1 funding round and has made 1 acquisition. The firm primarily invests in companies based in United States and Italy. Its portfolio is spread across a wide range of sectors from Chemicals and Materials to Healthcare. Most recently it acquired stakes in Brothers International Food on Apr 22, 2026.
Overall SK Capital portfolio has seen 1 IPO and 11 acquisitions, namely Perimeter Solutions, Halo Pharma and AEB. A lot of funds co-invest with SK Capital, with names like Bain Capital Life Sciences sharing a substantial percentage of its portfolio.
SK Capital has a team of 55 people, including 17 partners.
Key Metrics
Founded Year
2008
Location
New York City, United States
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
SK Capital's Portfolio
SK Capital has a portfolio of 21 companies. They have invested in a total of 21 companies. Their most recent investment was in Swixx BioPharma (PE round) on Dec 15, 2025. Here are the most recent investments by SK Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Dec 15, 2025 | PE | 6158 | ||
Mar 31, 2025 | Seed | 3626 | - | |
Sep 14, 2023 | PE | 3880 | - | |
Sep 07, 2022 | PE | 4511 | - |
SK Capital has acquired 36 companies. Their most recent acquisition was of Brothers International Food on Apr 22, 2026. Here are the most recent acquisitions by SK Capital:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Apr 22, 2026 | Distributor of fruits and vegetables | - | 2000 | |
Mar 06, 2025 | Provider of physical properties testing solutions for quality control | - | - | |
Feb 21, 2025 | Developer of gene therapies for severe genetic and rare diseases | $136M | 1992 | |
Dec 05, 2024 | Manufacturer of decorative toppings and inclusions, specializing in bulk orders and offering a wide range of products to the food industry | - | 1996 |
Here is the portfolio snapshot of SK Capital:
Investments by Year
The maximum number of investments were made in 2019
Acquisitions by Year
The maximum number of acquisitions were made in 2017
Portfolio by Location
Companies are primarily in United States and Italy
Portfolio by Sector
Companies are primarily in Chemicals and Materials
Team profile of SK Capital
SK Capital has a team of 55 members including 17 Partners and 14 Principals located in United States, China and 2 more locations. SK Capital's team does not sit on the board of any company as of now.Here is a list of top team members in SK Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | Chicago | - | ||
Partner | - | - | - | |
Partner | Charleston | - | ||
Partner | Wilmington | - | - | |
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | New York | - |
Co-investors of SK Capital
Over the past 18 years, 11 investors have co-invested in SK Capital's portfolio companies.
- Top Co-investors of SK Capital: 11 investors entered a company along with SK Capital. These include investors like Bain Capital Life Sciences (1 company).
SK Capital News
•
•
•
•
•
•
SK Capital appoints new head of portfolio value creation initiativesPrivate Equity Wire•May 01, 2026•SK Capital
•
Siegfried Obtains Antitrust Clearance for Acquisition of Drug Substances Sites in US and AustraliaWebDisclosure•Apr 24, 2026•Siegfried, Purisys, Extractas, SK Capital and 1 other
•
NYC private equity firm acquires Rochester-based Brothers InternationalRochester Business Journal•Apr 22, 2026•SK Capital
•
•
Catchment Capital to Acquire Isolatek International from SK Capital PartnersBusiness Wire•Apr 21, 2026•Catchment Capital, Isolatek, SK Capital
